The #ASCOQLTY24 DEADLINE is in 2 weeks!

Submit your high-impact research to the BEST meeting of the year; the ASCO Quality Care Symposium 2024 collects the brightest minds in quality, safety, & affordability.

🚨Abstracts are DUE Tuesday 5/21/2024

👉conferences.asco.org/quality/abstra…

#ASCOQLTY24 abstract submissions are due by May 21!

Share your science at the primary meeting for innovative, data-driven, interdisciplinary cancer science that will help improve the quality of cancer care.

Submit here: brnw.ch/21wJGsU Raymond Osarogiagbon, MBBS, FACP Fumiko Ladd Chino, MD

Looking forward to this #asco24 Ed Session on global innovations in rural oncology care. @asco dailynews.ascopubs.org/do/asco24-educ…

Students, Fellows and Early Career attendees at #asco24 - make sure to check out these opportunities offered in a lounge space dedicated to you! ⁦ASCO⁩ ⁦Mandy Davis Aitken⁩ connection.asco.org/tec/career/pro…

We’re accepting comments on our draft guideline protocol treatment of #multiplemyeloma . Submit your feedback by May 24. ➡️ brnw.ch/21wJFDn #mmsm

The Women’s Networking Center (WNC) at ASCO this year has now opened up their sign up for quick career conversations. m.signupgenius.com/#!/showSignUp/… Hematology & Oncology Women Physicians Group—HOWPG #ASCO24

🚨Attention senior fellows attending #ASCO24 ! Sign up for Mock Job Interviews in the #TECLounge . 🏥

Ana I. Velázquez Mañana, MD MSc (she/her/ella) Ramy Sedhom, MD Fernando Diaz, MD Jacob J. Adashek, DO

Link to signup 👉signupgenius.com/go/30E0A45A9A9…

💥The 2024 #TECLounge Career Conversations 👥sign up is OPEN! All #TECLounge attendees can sign-up for a 25-minute Career Conversation on a variety of training and career development topics! 🔥
signupgenius.com/go/30E0A45A9A9…
Ana I. Velázquez Mañana, MD MSc (she/her/ella) Ramy Sedhom, MD Fernando Diaz, MD Jacob J. Adashek, DO

We’re encouraged the cmte is working to advance #telehealth leg. Urge your lawmakers to extend telehealth flexibilities to help ensure pts have uninterrupted access to high-quality, equitable #cancercare regardless of geography, etc. asco.quorum.us/campaign/55362/ #ASCOAdvocacy

Thanks, FDA, for this great discussion on biosimilar drug products that covers switching between biosimilars & their biologic reference product/brand-name counterparts as well as the safety outcomes associated when switching. #ASCOAdvocacy

We appreciate FDA final rule to regulate all vitro diagnostic (IVD) tests, including laboratory-developed tests (LDTs), to ensure more patients can efficiently and accurately benefit from these tests.

More: brnw.ch/21wJypj #ASCOAdvocacy

Going to #ASCO24 ? Here are some tips to optimize your conference experience:
connection.asco.org/tec/career/mak…
dailynews.ascopubs.org/do/preparing-a…

🚨With #ASCO2024 right around the corner, the #TECAG is thrilled to announce the 🌟NEW Trainee & Early Career Lounge‼️ 🌟 We have outgrown our previous location due to the overwhelming popularity of the #TECLounge . 🏆

Ana I. Velázquez Mañana, MD MSc (she/her/ella) Ramy Sedhom, MD Fernando Diaz, MD Jacob J. Adashek, DO

Big news: Important steps by the Senate to end life threatening drug shortages. I was honored to represent ASCO and our patients in the hearing that prompted this draft bill. #ASCOAdvocacy

It's been so exciting to witness the ASCO Oncology Summer Internship Program's success in sparking medical students' interest in oncology. Congrats to all the students and sites set to participate in the 2024 OSI!

Glecirasib Shows Efficacy and Safety in KRAS G12C–Mutated NSCLC ascopost.com/news/may-2024/… #LCSM #lungcancer #oncology #ASCOPlenarySeries

The trainee lounge is such a lovely haven for trainees during the ASCO annual meetings. The new lounge has a lot more space and some new amenities. So excited to see it.

Last call! Join us for the #TAPUR Study Virtual Grand Rounds on May 6 to learn about the ongoing TAPUR Study #ClinicalTrials conducted by ASCO. Expert speakers include Richard Schilsky Janet Freeman-Daily & Dr. Jens Rueter.

Register: brnw.ch/21wJsW6 #OncTwitter #PrecisionMedicine